LIGHT SWITCH BIO

By repurposing underutilized drugs limited by toxicity issues or generics, we provide partnering pharmaceutical developers the potential to revive lost or unrealized market value. By repurposing drugs that failed in clinical trials due to toxicity issues, we provide the added potential to salvage the returns from sunk costs.​... By repurposing toxic systemic drugs into light-targeted pro-drugs, we aim to: avoid their costly off-target toxicities for patients, simplify care continuums for physicians, and revive the value of toxic drugs with de-risked pipelines for developers... Formed as a spin-out from Massey Cancer Center at Virginia Commonwealth University, our team is working hard to develop the first photoactivated chemotherapy on the market. We aim to minimize the risks of pharmaceuticals with laser-precision technologies for everyone, starting with patients.​

Also known as: Light Switch Bio, LLC

Primary location: Richmond United States